MedPath

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

Phase 3
Recruiting
Conditions
Sublobar Resection
Frozen Section
Lung Adenocarcinoma
Interventions
Procedure: Sublobar Resection
Registration Number
NCT06031181
Lead Sponsor
Fudan University
Brief Summary

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
390
Inclusion Criteria
  1. Patients who sign the informed consent form and are willing to complete the study according to the plan;
  2. Aged from 18 to 80 years old;
  3. ECOG equals 0 or 1;
  4. Not receiving lung cancer surgery before;
  5. Resectable peripheral cT1N0M0 tumors;
  6. Single lung nodules with ground-glass dominant or pure ground-glass on CT, or multiple lung nodules with the major lesion being the aforementioned nodules;
  7. Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
  8. Not receiving chemotherapy or radiotherapy before.
Exclusion Criteria
  1. Not cT1N0M0;
  2. Cannot be completely resected by sublobar resection;
  3. Invasive lung adenocarcinoma or not lung adenocarcinoma diagnosed cytologically or pathologically;
  4. Receiving lung cancer surgery before;
  5. Receiving radiotherapy or chemotherapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Sublobar resectionSublobar ResectionSublobar resection is performed for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
Primary Outcome Measures
NameTimeMethod
5-year recurrence-free survival5 years

The event is defined as the tumor recurrence.

Secondary Outcome Measures
NameTimeMethod
5-year overall survival5 years

The event is defined as the death due to any causes.

Trial Locations

Locations (1)

Fudan University Cancer Center

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath